GenMont Biotech Incorporation announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced sales was TWD 79.375 million compared to TWD 89.460 million a year ago. Operating income was TWD 23.458 million compared to TWD 19.430 million a year ago. Net income was TWD 29.142 million compared to TWD 15.956 million a year ago. Basic earnings per share was TWD 0.33 compared to TWD 0.18 a year ago. For the nine months, sales was TWD 238.349 million compared to TWD 266.788 million a year ago. Operating income was TWD 60.339 million compared to TWD 62.682 million a year ago. Net income was TWD 53.205 million compared to TWD 61.292 million a year ago. Basic earnings per share was TWD 0.6 compared to TWD 0.69 a year ago.